Climate change stands as one of the most pressing challenges of our time, affecting various aspects of our planet and human existence. Amid discussions about its environmental consequences, we often
By delivering vaccines to the gut, oral vaccines can trigger ‘mucosal immunity’ which prevents pathogens infecting the body by producing a protective response in the areas of the body where
Poolbeg Pharma (LON:POLB) Chief Executive Officer Jeremy Skillington talks us through the Poolbeg September 2023 company presentation. Poolbeg Pharma (LON:POLB, OTCQB: POLBF), is a clinical-stage biopharmaceutical company focusing on infectious and other prevalent
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost
Warnings about the potential threats of artificial intelligence (AI) technology have been coming from various industries. However, one of Britain’s largest drug firms, GlaxoSmithKline (GSK), believes that the use of
Poolbeg Pharma (LON:POLB) Scientific Advisor Dr Paula Maguire outlines her experience and what she’s so excited about with Poolbeg. Poolbeg Pharma fosters data-driven innovation and the most advanced scientific practices in
Artificial intelligence is everywhere. According to GlobalData forecasts, every segment of the AI market is expected to grow in the coming decade and it will be worth around $909 billion
Warnings about the potential threats of artificial intelligence (AI) technology have been coming thick and fast from a wide range of industries. But the use of cutting-edge AI could benefit
The field of drug discovery is challenging and time-consuming, but generative artificial intelligence (AI) has the potential to revolutionize this process. Generative AI, a subfield of AI, focuses on creating
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
